动物血浆製品及衍生市场（依动物种类、衍生类型、最终用户及应用划分）－2025-2032年全球预测

预计到 2032 年，动物血浆製品及衍生市场规模将达到 27.9 亿美元，复合年增长率为 7.90%。

关键市场统计数据
基准年 2024	15.2亿美元
预计年份：2025年	16.3亿美元
预测年份 2032	27.9亿美元
复合年增长率 (%)	7.90%

针对动物血浆製品及其衍生的全面指南，为多学科相关人员明确科学、监管和供应链方面的优先事项。

动物血浆製品及其衍生与生命科学、食品加工、兽医学和工业生物技术等领域密切相关，需要从技术、监管和商业性等多个观点进行综合考虑。本执行摘要係统地评估了该领域的当前趋势，检验了影响竞争力和营运重点的因素，包括产品衍生、终端应用和供应链特征。分析从血清和纤维蛋白原等生物原料入手，逐步深入到从细胞培养到营养补充剂等下游应用，并将这些原料置于传统和新兴价值链中进行探讨。

本导言强调了相关人员需要在科学严谨性和供应链弹性之间取得平衡。筹资策略的转变、生物医学和食品级衍生品质期望的不断提高以及需求的跨领域性，凸显了综合决策的重要性。因此，本报告着重提供实际可行的见解，以协调实验室需求、法规遵循和商业性需求，帮助企业优先投资于品质保证、供应商关係和特定应用产品开发。

技术进步、不断变化的生物安全期望和永续性压力如何共同作用，重塑该行业的采购、产品一致性和供应商整合。

近年来，主要受技术和政策驱动的趋势，已导致供应商、製造商和终端用户对待动物血浆衍生产品的方式发生变革性变化。细胞培养技术和组织工程平台的进步提高了对高品质血清和白蛋白的需求，促使供应商投资于可追溯性系统和更完善的品管流程。同时，加工和分离技术的创新提高了免疫球蛋白和纤维蛋白原製剂的一致性，使其在生物医学研究和特定工业应用中得到更广泛的应用。

不断变化的法规正在重塑采购和检验实践。更严格的文件要求和生物安全期望提升了供应商审查和原产地保证的重要性，尤其是在涉及人类健康的应用领域。同时，永续性考量正在推动上游工程采购和废弃物管理的变革，鼓励采用闭合迴路实践和替代筹资策略。这些协同效应正在推动供应商组合的重组，并促使寻求确保和品管的企业进行垂直整合。因此，那些将研发重点与供应商能力和监管前瞻性相结合的企业，能够在最大限度地减少营运中断的同时，抓住新兴技术机会。

了解 2025 年关税调整如何重塑依赖特殊生物成分的组织的采购、供应商多元化和库存策略。

2025年美国关税调整和贸易政策转变对整个供应链产生了重大影响，改变了依赖动物血浆衍生物企业的成本结构、供应商选择和库存策略。进口商和下游製造商正在透过重新评估采购区域、加快供应商多元化计划以及尽可能优先选择近岸生产来应对这些变化。这些战术性应对措施也导致了营运方面的改变，例如延长供应商资格认证期限和扩大品质保证测试范围，以确保符合监管和客户规范。

关税环境也影响商业谈判和合约条款，买家寻求更弹性价格设定，供应商则希望签订更长期的协议以稳定收入。物流模式也正在做出相应调整，企业重新分配区域配送中心的库存缓衝，以减少潜在的海关延误和成本波动。对于血清和特殊蛋白质的技术使用者而言，采购部门在平衡供应安全和成本控制的同时，也越来越优先考虑具有本地生产能力的成熟供应商。整体而言，关税环境凸显了供应链透明度、冗余性和合约弹性对于维持检验时限和生产连续性的重要性。

透过深度細項分析，将动物来源、衍生特性、终端用户合规性和多样化应用联繫起来，以製定客製化的采购和研发策略。

细分市场分析揭示了不同动物种类、衍生产品类型、最终用户和应用领域之间的差异化动态，这些差异对供应链设计和产品开发有着不同的影响。就动物种类（禽类、牛、羊、猪）而言，原料供应、病原体筛检程序以及文化和监管偏好等方面的差异会影响特定应用领域对原料的选择。例如，某些大批量应用会优先选择牛产品，而不同的功能特性则会导致选择猪源或羊源原料。同时，对牛、纤维蛋白原、免疫球蛋白、血清白蛋白和凝血酶等衍生产品类型的检验表明，每种衍生都有其独特的加工、稳定性和品质保证要求，这些要求会影响储存、处理和最终用途检验。

透过比较食品製造商、製药公司和兽医护理等终端用户群体，可以发现他们在合规框架和绩效预期方面存在差异。食品加工商强调食品安全认证和过敏原管理，製药公司优先考虑可追溯性和监管文件，而兽医使用者则需要在疗效、成本和保质期之间取得平衡。基于应用领域的差异（动物饲料、生物医学研究、细胞培养基、食品加工、营养保健品、宠物食品产业、药品和化妆品、组织工程）也反映在纯度、功能规格和价值实现方面的差异。例如，生物医学研究和细胞培养需要严格的批次间一致性和污染控制，而动物饲料和宠物食品应用则允许更广泛的规格范围，同时要求经济高效的供应。整合这些细分观点，有助于相关人员制定既能反映技术限制又能体现商业性优先事项的采购、品管和产品开发蓝图。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和物流现实决定供应的连续性、合规性和供应商选择。

区域性洞察揭示了地缘政治、物流和监管因素如何影响动物血浆衍生的获取，并影响生产者和消费者的策略选择。在美洲，接近性主要生物技术群聚和成熟的畜牧生产体系，为科研级和工业应用提供了强大的供应链支援。该地区拥有完善的低温运输物流基础设施和法律规范，促进了区域内的跨境贸易。欧洲、中东和非洲地区（EMEA）的情况则较为复杂，某些司法管辖区拥有严格的管理体制，而有些司法管辖区则拥有新兴的生产能力。这要求企业调整其合规策略，并投资与当地供应商建立伙伴关係，以确保产品品质和供应的连续性。

亚太地区正日益成为一个重要的枢纽，它融合了大规模的动物生产能力​​以及不断发展的生物製造和研究。该地区的物流规模和成本效益为全球企业带来了许多优势，但采购者必须应对各地不同的监管环境和品质保证标准。在所有地区，当地的监管要求、运输基础设施和动物来源的可用性都会影响采购决策和策略供应商合作。因此，能够分析区域优势并结合特定应用需求的企业，将更有利于优化供应连续性、缩短前置作业时间并管理合规风险。

竞争定位和供应商策略突显了专业知识、品质投资和伙伴关係模式，这些因素决定了能否获得高纯度、大批量的衍生物。

主要企业之间的竞争趋势揭示了其不同的策略方针。有些企业专注于高纯度生物医学应用衍生的专业技术，而有些企业则强调食品和饲料产业的规模化和成本效益。市场地位受到企业在品质保证系统、生物安全认证和供应链可追溯性解决方案方面的投资的影响，这些投资旨在满足受监管的终端用户需求。投资于专有加工技术和严格检验通讯协定的企业，对需要可重复性和文件记录的製药和组织工程客户而言，变得越来越有吸引力。

策略联盟和契约製造关係也是竞争优势的建构要素。那些将前端流程整合到附加价值服务（例如定製配方协助、法规文件支援和应用特定测试）中的公司，往往能够与研究机构和专业製造商建立互惠互利的合作关係。同时，专注于大宗商品级衍生产品的生产商则利用其规模优势和成本控制，在饲料和宠物食品等大宗应用市场中保持市场份额。透过观察这些多元化的策略，相关人员可以根据自身业务需求评估潜在供应商，并优先选择那些能够满足产品规格、合规要求和长期可靠性要求的合作伙伴。

为领导者提供切实可行的、优先考虑的行动方案，以加强供应链、整合研发和采购，并透过有针对性的供应商和产品策略创造价值。

产业领导者应实施一系列切实可行的措施，以增强韧性，使研发重点与供给能力相匹配，并在各种应用领域创造价值。首先，投资于整合原产地检验、生物安全审核和分析检验的供应商合格框架，将降低下游风险，并加快受监管应用领域的品质保证速度。其次，透过地理和物种多元化供应商网络，可以获得具有特定功能特性的衍生，同时降低单点故障风险。第三，透过供应商协作测试和技术转移通讯协定，将采购与研发连结起来，将加速产品开发，并确保实验室规模的性能能够转化为生产规模的可靠性。

此外，企业应制定适应性强的合约模式，在价格稳定性和品质及数量调整的灵活性之间取得平衡，并采用反映应用关键性而非统一库存规则的库存策略。对于产品开发人员而言，优先开发能够适应尽可能广泛原材料差异的配方，可以降低对供应商差异的依赖。最后，积极与监管机构和标准制定机构沟通，影响并预测合规要求，可以缩短产品上市时间并减少返工。透过落实这些建议，企业可以将这些洞察转化为具有韧性的采购、稳健的产品平臺和可持续的竞争优势。

采用严谨的多方法研究途径，结合相关人员访谈、技术整合和供应链分析，以产生经实务验证的营运建议。

这些研究结果所依据的调查方法结合了关键相关利益者对话、技术文献综述和供应链分析，以确保为可操作的建议提供坚实的证据基础。关键对话包括与来自食品、製药和动物医药行业的采购经理、研发经理和品质保证专业人员进行结构化访谈，从而获得关于采购限制、品质期望和物流实际情况的第一手观点。作为这些对话的补充，研究人员还查阅了技术文献和行业指南，以明确衍生产品的特定加工要求以及与各种最终用途相关的生物安全注意事项。

为识别通用瓶颈和提升韧性的关键因素，我们开展了供应链映射和贸易流量分析，重点关注低温运输要求、跨境合规性和供应商集中度。透过对定性资讯和营运指标进行三角验证，我们制定了切实可行的建议，重点是供应商资格认证、合约设计和库存管理。我们透过记录假设、从多个相关人员的观点检验结果以及确保分析过程的透明度，从而保证了调查方法的严谨性，并增强了研究结果对实践者的可复製性和可信度。

策略整合，重点在于检验、来源多元化和跨职能协作，以确保复杂生物供应链的韧性和技术性能。

摘要，动物血浆製品及其衍生兼具科学复杂性和操作敏感性，需要采取综合策略来管理品质、合规性和连续性。加工和应用科学的进步提高了人们对可追溯性和批间一致性的期望，而监管和贸易趋势则凸显了多元化和灵活采购实践的重要性。积极主动地将严格的供应商筛选、策略性的地域多元化以及研发和采购部门之间的协作相结合的相关人员，将更有能力降低风险并抓住生物医学、食品和兽医领域的机会。

最终，该行业将奖励那些将生物材料视为更广泛的产品和研究生态系统中关键组成部分，而不是仅仅将其视为商品的机构。透过投资检验、发展策略供应商关係以及将监管前瞻性纳入采购决策，机构可以确保营运韧性，并维持支持最终用户信心和创新所需的技术性能。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 喷雾干燥猪血浆的应用正在迅速扩展，透过调节断奶仔猪的肠道环境来改善其健康状况。
• 在欧洲获得监管部门批准，在宠物食品中添加牛血浆蛋白（以增强免疫力和促进消化）。
• 采用先进的超过滤和层析法技术提高动物血浆中免疫球蛋白的纯度
• 血浆处理公司与生技公司进行策略合作，共同开发畜牧业的治疗性免疫球蛋白产品。
• 亚太地区对喷雾干燥设施的投资正在增加，以确保高品质动物血浆衍生产品的本地供应。
• 区块链溯源平台的出现，用于检验动物血浆原料的永续来源
• 整合紫外线和伽马射线等病原体灭活技术，以提高等离子体衍生饲料原料的安全性
• 开发源自动物血浆的新型生物活性胜肽组成，并将其应用于功能性水产饲料，以改善鱼类健康。
• 消费者对优质宠物食品配方中非基因改造、经认证的血浆蛋白的需求日益增长，以满足洁净标示的要求。
• 非洲猪瘟疫情对全球猪血浆供应链的影响：价格波动与采购挑战

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依动物类型分類的动物血浆製品及衍生市场

• 鸟类
• 牛
• 羊
• 猪

9. 依衍生物类型分類的动物血浆製品及衍生市场

• 牛
• 纤维蛋白原
• 免疫球蛋白
• 血清白蛋白
• 凝血酶

第十章 依最终用户分類的动物血浆製品及衍生市场

• 食品製造商
• 製药公司
• 兽医

第十一章 动物血浆製品及衍生市场（依应用领域划分）

• 动物饲料
• 生物医学研究
• 细胞培养基
• 食品加工
• 营养补充品
• 宠物食品业
• 药品和化妆品
• 组织工程

第十二章 各地区动物血浆製品及衍生市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 依组别分類的动物血浆製品及衍生市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国动物血浆製品及衍生市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • ACROBiosystems Inc.
  • Alfa Laval Corporate AB
  • ANZCO Foods Limited
  • Auckland BioSciences Ltd.
  • BioChemed Services
  • Biowest Company
  • Bovogen Biologicals Pty Ltd.
  • Canvax Reagents SL
  • Ebrator Biochemicals Inc.
  • Kraeber & Co. GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • Meiji Holdings Co., Ltd.
  • Merck KGaA
  • Pel-Freez, LLC
  • Rockland Immunochemicals, Inc.
  • Rocky Mountain Biologicals
  • Scripps Laboratories, Inc.
  • Sigma-Aldrich
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific Inc.

The Animal Blood Plasma Products & Derivatives Market is projected to grow by USD 2.79 billion at a CAGR of 7.90% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 1.52 billion
Estimated Year [2025]	USD 1.63 billion
Forecast Year [2032]	USD 2.79 billion
CAGR (%)	7.90%

A comprehensive orientation to animal blood plasma products and derivatives that clarifies scientific, regulatory, and supply chain priorities for interdisciplinary stakeholders

The animal blood plasma products and derivatives landscape intersects life sciences, food processing, veterinary care, and industrial biotechnology, demanding a synthesis of technical, regulatory, and commercial perspectives. This executive summary introduces a structured appraisal of the sector's current dynamics, examining product derivatives, end-use applications, and supply chain characteristics that together shape competitive and operational priorities. By framing the conversation around biological inputs such as serum and fibrinogen as well as downstream applications spanning cell culture and nutrition, the analysis situates these materials within both traditional and emerging value chains.

This introduction highlights the necessity for stakeholders to balance scientific rigor with supply chain agility. Shifts in sourcing strategies, evolving quality expectations for biomedical and food-grade derivatives, and the cross-sectoral nature of demand underscore the importance of integrated decision-making. Consequently, the report emphasizes practical insights that align laboratory needs, regulatory compliance, and commercial imperatives, enabling organizations to prioritize investments in quality assurance, supplier relationships, and application-specific product development.

How technological advances, evolving biosafety expectations, and sustainability pressures are jointly reshaping sourcing, product consistency, and supplier integration in the sector

Recent developments have triggered transformative shifts in how suppliers, manufacturers, and end-users approach animal blood plasma derivatives, with technology and policy acting as primary accelerants. Advances in cell-culture techniques and tissue-engineering platforms have increased demand for high-quality serum and albumin, prompting suppliers to invest in traceability systems and enhanced quality control processes. Concurrently, innovations in processing and fractionation have improved the consistency of immunoglobulin and fibrinogen preparations, enabling wider adoption in both biomedical research and specialized industrial uses.

Regulatory evolution is reshaping procurement and validation approaches. Stricter documentation and biosafety expectations have elevated the importance of supplier vetting and provenance assurance, especially for applications with human-health implications. In parallel, sustainability considerations are prompting upstream changes in sourcing and waste management, incentivizing closed-loop practices and alternative sourcing strategies. These converging forces are driving a reconfiguration of supplier portfolios and encouraging vertical integration by firms seeking to secure raw materials and control quality. As a result, organizations that align R&D priorities with supplier capability and regulatory foresight are positioning themselves to capitalize on emerging technical opportunities while mitigating operational disruption.

Understanding how 2025 tariff adjustments reshaped procurement, supplier diversification, and inventory strategies for organizations dependent on specialized biological inputs

Tariff adjustments and trade policy shifts in the United States for 2025 have had material implications across the supply chain, altering cost structures, supplier selection, and inventory strategies for businesses reliant on animal blood plasma derivatives. Importers and downstream manufacturers have responded by reassessing sourcing geographies, accelerating supplier diversification plans, and increasing emphasis on nearshoring where feasible. These tactical responses have been accompanied by operational changes such as extended supplier qualification timelines and expanded quality assurance testing to ensure conformity with both regulatory and customer specifications.

The tariff environment has also influenced commercial negotiations and contractual terms, with buyers seeking more flexible pricing arrangements and suppliers negotiating longer-term contracts to stabilize revenue streams. Logistic patterns have adjusted in response, with companies reallocating inventory buffers across regional distribution centers to mitigate potential customs delays and cost volatility. For technology-driven users of serum and specialized proteins, procurement teams are balancing the need for high-certainty supply with cost management, often prioritizing validated suppliers with regional production capabilities. Overall, the tariff context has increased the premium on supply chain transparency, redundancy, and contractual agility to sustain research timelines and production continuity.

Deep segmentation insights that connect animal source, derivative characteristics, end-user compliance, and diverse applications to inform tailored sourcing and R&D strategies

Segmentation analysis reveals differentiated dynamics when observed through the lenses of animal type, derivative type, end-user, and application, each offering distinct implications for supply chain design and product development. When considering animal type-Avian, Bovine, Ovine, and Porcine-differences in source availability, pathogen screening protocols, and cultural or regulatory preferences influence which raw materials are favored for specific applications, with bovine-derived products commonly prioritized for certain high-volume applications and porcine or ovine materials selected where functional properties differ. In parallel, examining derivative types such as Fetal Bovine Serum, Fibrinogen, Immunoglobulin, Serum Albumin, and Thrombin clarifies that each derivative carries unique processing, stability, and quality assurance requirements that affect storage, handling, and end-use validation.

End-user segmentation across Food Manufacturers, Pharmaceutical Companies, and Veterinary sectors highlights divergent compliance frameworks and performance expectations: food processors emphasize food-safety certifications and allergen control, pharmaceutical firms prioritize traceability and regulatory documentation, and veterinary users balance efficacy with cost and shelf-life considerations. Application-driven distinctions-spanning Animal Feed, Biomedical Research, Cell Culture Media, Food Processing, Nutrition Supplements, Pet Food Industry, Pharmaceuticals & Cosmetics, and Tissue Engineering-illustrate variation in purity, functional specification, and value capture. For instance, biomedical research and cell culture demand stringent lot-to-lot consistency and contamination controls, while applications in animal feed and pet food tolerate broader specification ranges but require cost-efficient supply. Integrating these segmentation perspectives enables stakeholders to tailor sourcing, quality management, and product development roadmaps that reflect both technical constraints and commercial priorities.

Regional dynamics and logistical realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine supply continuity, compliance, and supplier choice

Regional insights illuminate how geopolitical, logistical, and regulatory factors shape access to animal blood plasma derivatives and influence strategic choices by producers and consumers. In the Americas, proximity to major biotech clusters and established animal agriculture systems supports robust supply chains for both research-grade and industrial applications, with infrastructure geared toward cold-chain logistics and regulatory oversight that facilitates cross-border trade within the region. Europe, Middle East & Africa presents a complex mosaic where stringent regulatory regimes in certain jurisdictions coexist with emerging production capacity in others, prompting companies to adapt compliance strategies and invest in regional supplier partnerships to assure quality and continuity.

Asia-Pacific has become increasingly pivotal, combining large-scale animal production capacity with expanding biomanufacturing and research activity. This region's logistical scale and cost efficiencies can offer advantages to global firms, though buyers must navigate heterogeneous regulatory landscapes and varying quality assurance norms. Across all regions, regional regulatory expectations, transport infrastructure, and source animal availability drive procurement decisions and strategic supplier alignment. Consequently, organizations that map regional strengths against application-specific requirements are better positioned to optimize supply continuity, reduce lead times, and manage compliance risk.

Competitive positioning and supplier strategies that delineate specialization, quality investment, and partnership models shaping access to high-purity and large-volume derivatives

Competitive dynamics among key companies reveal differentiated strategic approaches, with some firms focusing on specialization in high-purity derivatives for biomedical applications while others emphasize scale and cost-efficiency for food and feed segments. Market positions are influenced by investments in quality assurance systems, biosafety certifications, and supply chain traceability solutions that respond to the demands of regulated end-users. Organizations investing in proprietary processing technologies and rigorous validation protocols are increasingly attractive to pharmaceutical and tissue-engineering customers that require reproducibility and documentation.

Strategic partnerships and contract manufacturing relationships also shape competitive advantage. Firms that integrate forward into value-added services-such as custom formulation support, regulatory dossier assistance, and application-specific testing-tend to capture higher-margin relationships with research institutions and specialty manufacturers. Meanwhile, producers focused on commodity-grade derivatives leverage scale and cost management to maintain relevance in large-volume applications like animal feed and pet food. Observing these varied strategies enables stakeholders to benchmark potential suppliers against operational needs and to prioritize partners whose capabilities align with product specifications, compliance requirements, and long-term reliability.

Practical and prioritized actions for leaders to fortify supply chains, synchronize R&D with procurement, and capture value through targeted supplier and product strategies

Industry leaders must adopt a set of pragmatic, actionable steps to strengthen resilience, align R&D priorities with supply capabilities, and capture value across applications. First, investing in supplier qualification frameworks that integrate provenance verification, biosafety audits, and analytical validation will reduce downstream risk and shorten time-to-assurance for regulated applications. Second, diversifying supplier networks geographically and across animal sources can mitigate exposure to single-point disruptions while enabling access to derivatives with specific functional properties. Third, aligning procurement and R&D teams through joint supplier trials and technical transfer protocols will accelerate product development and ensure that laboratory-scale performance translates into production-scale reliability.

Additionally, companies should develop adaptive contracting approaches that balance price stability with flexibility for quality and volume adjustments, and they should incorporate inventory strategies that reflect application criticality rather than uniform stocking rules. For product developers, prioritizing formulations that accommodate broader input variability where possible will reduce sensitivity to supplier fluctuation. Finally, engaging proactively with regulators and standard-setting bodies to influence or anticipate compliance requirements will yield advantages in time-to-market and reduce rework. By operationalizing these recommendations, organizations can transform insight into resilient procurement, robust product pipelines, and sustained competitive differentiation.

A rigorous, multi-method research approach combining stakeholder interviews, technical synthesis, and supply chain mapping to generate validated operational recommendations

The research methodology underpinning these insights combines primary stakeholder engagement, technical literature synthesis, and supply chain analysis to ensure a robust evidence base that supports actionable recommendations. Primary engagement included structured interviews with procurement leads, R&D heads, and quality assurance professionals across food, pharmaceutical, and veterinary organizations, providing firsthand perspectives on sourcing constraints, quality expectations, and logistical realities. Complementing these dialogues, a review of technical literature and industry guidelines clarified derivative-specific processing requirements and biosafety considerations relevant to different end uses.

Supply chain mapping and trade-flow analysis were conducted to identify common bottlenecks and resilience levers, with attention to cold-chain demands, cross-border compliance, and supplier concentration. Triangulation of qualitative inputs with operational indicators allowed for the development of pragmatic recommendations focused on supplier qualification, contractual design, and inventory management. Throughout, methodological rigor was maintained by documenting assumptions, validating findings through multiple stakeholder perspectives, and prioritizing transparency in analytic steps to support reproducibility and confidence in the implications drawn for practitioners.

A strategic synthesis that emphasizes validation, supplier diversification, and cross-functional alignment to ensure resilience and technical performance in complex biological supply chains

In summary, animal blood plasma products and derivatives occupy a nexus of scientific complexity and operational sensitivity that requires integrated strategies to manage quality, compliance, and continuity. Advances in processing and application science have elevated expectations for traceability and lot consistency, while regulatory and trade dynamics have amplified the need for diversified sourcing and agile procurement. Stakeholders who proactively combine rigorous supplier qualification, strategic geographic diversification, and alignment between research and procurement functions will better mitigate risk and seize opportunities across biomedical, food, and veterinary arenas.

Ultimately, the sector rewards organizations that treat biological inputs not merely as commodities but as critical components of broader product and research ecosystems. By investing in validation, fostering strategic supplier relationships, and embedding regulatory foresight into procurement decisions, institutions can ensure operational resilience and maintain the technical performance that underpins end-user trust and innovation.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rapid expansion of spray-dried porcine plasma use to enhance post-weaning piglet performance through gut health modulation
• 5.2. Regulatory clearance for bovine blood plasma protein inclusion in European pet food to boost immune function and digestion
• 5.3. Adoption of advanced ultrafiltration and chromatography techniques to increase immunoglobulin purity from animal blood plasma
• 5.4. Strategic collaborations between plasma processors and biotech firms to develop therapeutic immunoglobulin treatments for livestock
• 5.5. Increasing investment in Asia-Pacific spray-drying facilities to secure local supply of high-quality animal plasma derivatives
• 5.6. Emergence of blockchain-enabled traceability platforms for verifying sustainable sourcing of animal blood plasma raw materials
• 5.7. Integration of pathogen inactivation technologies such as UV and gamma irradiation to enhance safety of plasma-based feed ingredients
• 5.8. Development of novel bioactive peptide fractions from animal plasma for use in functional aquaculture feeds to improve fish health
• 5.9. Rising consumer demand for non-GMO certified blood plasma proteins in premium pet food formulations to meet clean label requirements
• 5.10. Impact of African swine fever outbreaks on global porcine plasma supply chains leading to price volatility and sourcing challenges

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Blood Plasma Products & Derivatives Market, by Animal Type

• 8.1. Avian
• 8.2. Bovine
• 8.3. Ovine
• 8.4. Porcine

9. Animal Blood Plasma Products & Derivatives Market, by Derivative Type

• 9.1. Fetal Bovine Serum
• 9.2. Fibrinogen
• 9.3. Immunoglobulin
• 9.4. Serum Albumin
• 9.5. Thrombin

10. Animal Blood Plasma Products & Derivatives Market, by End-User

• 10.1. Food Manufacturers
• 10.2. Pharmaceutical Companies
• 10.3. Veterinary

11. Animal Blood Plasma Products & Derivatives Market, by Application

• 11.1. Animal Feed
• 11.2. Biomedical Research
• 11.3. Cell Culture Media
• 11.4. Food Processing
• 11.5. Nutrition Supplements
• 11.6. Pet Food Industry
• 11.7. Pharmaceuticals & Cosmetics
• 11.8. Tissue Engineering

12. Animal Blood Plasma Products & Derivatives Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Animal Blood Plasma Products & Derivatives Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Animal Blood Plasma Products & Derivatives Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. ACROBiosystems Inc.
  • 15.3.2. Alfa Laval Corporate AB
  • 15.3.3. ANZCO Foods Limited
  • 15.3.4. Auckland BioSciences Ltd.
  • 15.3.5. BioChemed Services
  • 15.3.6. Biowest Company
  • 15.3.7. Bovogen Biologicals Pty Ltd.
  • 15.3.8. Canvax Reagents S.L.
  • 15.3.9. Ebrator Biochemicals Inc.
  • 15.3.10. Kraeber & Co. GmbH
  • 15.3.11. Lake Immunogenics, Inc.
  • 15.3.12. LAMPIRE Biological Laboratories, Inc.
  • 15.3.13. Meiji Holdings Co., Ltd.
  • 15.3.14. Merck KGaA
  • 15.3.15. Pel-Freez, LLC
  • 15.3.16. Rockland Immunochemicals, Inc.
  • 15.3.17. Rocky Mountain Biologicals
  • 15.3.18. Scripps Laboratories, Inc.
  • 15.3.19. Sigma-Aldrich
  • 15.3.20. TCS Biosciences Ltd.
  • 15.3.21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 135. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 136. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 137. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 138. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 139. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 140. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 141. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 142. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 143. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 144. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 145. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 148. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 149. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 150. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 151. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 152. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 153. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 154. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 155. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 158. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 159. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 160. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 161. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 162. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 163. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 164. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 165. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 166. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 167. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 175. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 177. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 179. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 180. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 181. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 182. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 183. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 184. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 185. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 188. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 189. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 190. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 191. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 192. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 193. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 194. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 195. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 196. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 197. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 198. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 199. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 200. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 201. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 202. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 203. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 204. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 205. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 208. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 209. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 210. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 211. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 212. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 213. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 214. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 217. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 218. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 219. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 220. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 221. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 222. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 223. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 224. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 225. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 226. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 227. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 230. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 231. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 232. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 233. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 234. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 235. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 236. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 237. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 238. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 239. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 240. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 241. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 242. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 243. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 244. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 245. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 246. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 247. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 248. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 249. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 250. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 251. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 252. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 253. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 254. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 255. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 256. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 257. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 260. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 261. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 262. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025-2032 (USD MILLION)
• TABLE 263. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 264. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 265. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 266. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 267. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 268. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 269. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 270. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 271. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2024 (USD MILLION)
• TABLE 272. NATO A